ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents
| dc.contributor.author | Larson Ode, Katie | |
| dc.contributor.author | Ballman, Manfred | |
| dc.contributor.author | Battezzati, Alberto | |
| dc.contributor.author | Brennan, Amanda | |
| dc.contributor.author | Chan, Christine L. | |
| dc.contributor.author | Hameed, Shihab | |
| dc.contributor.author | Ismail, Heba M. | |
| dc.contributor.author | Kelly, Andrea | |
| dc.contributor.author | Moran, Antoinette M. | |
| dc.contributor.author | Rabasa-Lhoret, Remi | |
| dc.contributor.author | Saxby, Nichole A. | |
| dc.contributor.author | Craig, Maria E. | |
| dc.contributor.department | Pediatrics, School of Medicine | |
| dc.date.accessioned | 2023-12-20T18:00:06Z | |
| dc.date.available | 2023-12-20T18:00:06Z | |
| dc.date.issued | 2022 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Ode KL, Ballman M, Battezzati A, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1212-1228. doi:10.1111/pedi.13453 | |
| dc.identifier.uri | https://hdl.handle.net/1805/37466 | |
| dc.language.iso | en_US | |
| dc.publisher | Wiley | |
| dc.relation.isversionof | 10.1111/pedi.13453 | |
| dc.relation.journal | Pediatric Diabetes | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
| dc.source | PMC | |
| dc.subject | CFTR modulator | |
| dc.subject | HEMT therapy | |
| dc.subject | Adolescents | |
| dc.subject | Children | |
| dc.subject | Cystic fibrosis related diabetes | |
| dc.title | ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents | |
| dc.type | Article |